BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31184445)

  • 1. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
    Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
    Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2139-2146. PubMed ID: 30034229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
    Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
    J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
    Media AS; Persson M; Tajhizi N; Weinreich UM
    Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
    [No Abstract]   [Full Text] [Related]  

  • 6. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.
    Dong W; Zhu Y; Du Y; Wang L; Feng X; Ma S
    Clin Respir J; 2020 Apr; 14(4):345-352. PubMed ID: 31876095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer.
    Jeppesen SS; Hansen NG; Schytte T; Nielsen M; Hansen O
    Lung Cancer; 2016 Oct; 100():90-95. PubMed ID: 27597286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
    Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
    Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of emphysema and airway obstruction in prognosis of lung cancer.
    Gullón JA; Suárez I; Medina A; Rubinos G; Fernández R; González I
    Lung Cancer; 2011 Feb; 71(2):182-5. PubMed ID: 20554345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    Yi YS; Ban WH; Sohng KY
    BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease in stage I non-small cell lung cancer that underwent anatomic resection: the role of a recurrence promoter.
    Kuo CH; Wu CY; Lee KY; Lin SM; Chung FT; Lo YL; Liu CY; Hsiung TC; Yang CT; Wu YC
    COPD; 2014 Aug; 11(4):407-13. PubMed ID: 24475998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy.
    Kim H; Yoo H; Pyo H; Ahn YC; Noh JM; Ju SG; Lee W; Park B; Kim JM; Kang N; Shin SH; Chung MP; Shin S; Kim HS; Park M; Park HY
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2273-2281. PubMed ID: 31631997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
    Ajimizu H; Ozasa H; Sato S; Funazo T; Sakamori Y; Nomizo T; Kuninaga K; Ogimoto T; Hosoya K; Yamazoe M; Tsuji T; Yoshida H; Itotani R; Ueno K; Kim YH; Muro S; Hirai T
    Sci Rep; 2021 Dec; 11(1):23677. PubMed ID: 34880386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].
    Qiang G; Yu Q; Liang C; Song Z; Shi B; Guo Y; Liu D
    Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):215-220. PubMed ID: 29587946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
    PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.